Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Synageva BioPharma Corp Announces 2.75 Million Share Proposed Public Offering Of Common Stock


Monday, 23 Sep 2013 04:10pm EDT 

Synageva BioPharma Corp announced that it intends to offer for sale 2.75 million shares of its common stock in an underwritten public offering. In connection with this offering, Synageva expects to grant to the underwriters a 30-day option to purchase up to an additional 412,500 shares of its common stock. If the underwriters exercise this option, Synageva will have offered 3.16 million shares of its common stock. Goldman, Sachs & Co. is acting as the sole book-running manager in the offering. 

Company Quote

72.12
-4.95 -6.42%
28 Aug 2014